Synchron Company

Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Investors
Funding Status:
Late Stage Venture
Technology:
['BioTech & HealthTech']
Number Of Exists:
Series A
Investors Number:
23.0
Employee Number:
1-10
Last Funding Date:
2022-12-15
Industry:
Med Tech
Headquarters:
Brooklyn, New York, United States
Total Funding:
130000000.0
Last Funding Type:
Series C
Founded Date:
2016-04-01
Investment Stage:
N/A
Estimated Revenue:
$50M to $100M
Investor Type:
Company